eISSN: 3023-6940
  • Home
  • Transcatheter bilateral superselective arterial embolization, a minimally invasive method for persistent hematuria in elderly and comorbid patients with bladder and prostate cancer

Original Research

Transcatheter bilateral superselective arterial embolization, a minimally invasive method for persistent hematuria in elderly and comorbid patients with bladder and prostate cancer


1 Harran University, Faculty of Medicine, Department of Urology, Sanlıurfa, Turkey
2 Harran University, Faculty of Medicine, Department of Radiology, Sanlıurfa, Turkey


DOI : 10.33719/yud.2021;16-2-841651
New J Urol. 2021; 16-(2):171-177

Abstract

Purpose: To evaluate the effect of tamsulosin 0.4 mg and silodosin 8 mg for the medical expulsive treatment in distal ureteral stones.

Material and Methods: Between January 2014 and December 2015, 184 patients with acute renal colic who were diagnosed  as distal ureteral stone (4 to 9 mm)  by computarized tomography were evaluated retrospectively. Patients were divided into three groups: first group (follow-up group) (n=59) took dexketoprofen 25 mg on-demand, second group (tamsulosin group) (n=64) took tamsulosin 0.4 mg daily and dexketoprofen 25 mg on-demand, third group (silodosin group) (n=61) took silodosin  8 mg daily and dexketoprofen 25 mg on-demand. All patients were observed for 4 weeks. Stone expul-sion rates, expulsion time, need for analgesics and adverse events were recorded.

Results: Stone expulsion rates were 63% in the follow-up group, 77% in the tamsulosin group and, 82% in the silodosin group. Need for analge-sics, pain episodes, expulsion time were higher in follow-up group than the other two groups. No seri-ous adverse events was recorded.

Conclusion:  Medical expulsive treatment is an option for uncomplicated distal ureteral stones. A statistically significant increase in the stone expul-sion rate and reduction for use of analgesics can be achieved with tamsulosin 0.4 mg and silodosin 8 mg in patients with distal ureteral stones.

Keywords: Medical expulsive treatment, alfa blocker, ureteral stone


Abstract

Purpose: To evaluate the effect of tamsulosin 0.4 mg and silodosin 8 mg for the medical expulsive treatment in distal ureteral stones.

Material and Methods: Between January 2014 and December 2015, 184 patients with acute renal colic who were diagnosed  as distal ureteral stone (4 to 9 mm)  by computarized tomography were evaluated retrospectively. Patients were divided into three groups: first group (follow-up group) (n=59) took dexketoprofen 25 mg on-demand, second group (tamsulosin group) (n=64) took tamsulosin 0.4 mg daily and dexketoprofen 25 mg on-demand, third group (silodosin group) (n=61) took silodosin  8 mg daily and dexketoprofen 25 mg on-demand. All patients were observed for 4 weeks. Stone expul-sion rates, expulsion time, need for analgesics and adverse events were recorded.

Results: Stone expulsion rates were 63% in the follow-up group, 77% in the tamsulosin group and, 82% in the silodosin group. Need for analge-sics, pain episodes, expulsion time were higher in follow-up group than the other two groups. No seri-ous adverse events was recorded.

Conclusion:  Medical expulsive treatment is an option for uncomplicated distal ureteral stones. A statistically significant increase in the stone expul-sion rate and reduction for use of analgesics can be achieved with tamsulosin 0.4 mg and silodosin 8 mg in patients with distal ureteral stones.

Keywords: Medical expulsive treatment, alfa blocker, ureteral stone